Director/PDMR Shareholding

RNS Number : 7369T
GlaxoSmithKline PLC
16 October 2017
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr D E Troy

b)

Position/status

SVP & General Counsel

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

 

b)

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 12 October 2017 on ADSs held in the Company's US Deferred Performance Share Plan.

c)

Price(s) and

volume(s)

Price(s)

Volume(s)

$41.02

377.925

$41.02

5.824

d)

Aggregated

information

 

Aggregated volume Price

 

 

 

 

383.749

$41.02

e)

Date of the transaction

2017-10-12

f)

Place of the transaction

 

New York Stock Exchange (XNYS)

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEQLFFDBFXFBD

Companies

GSK (GSK)
UK 100

Latest directors dealings